Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions

Hypersensitivity reactions from taxol.

R B Weiss, Ross C. Donehower, Peter H. Wiernik et al. · Journal of Clinical Oncology · 1990 · 1.2K citations

Medicine, Oncology, Pharmacology +9

Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases

Mariana Castells, Nichole M. Tennant, David E. E. Sloane et al. · Journal of Allergy and Clinical Immunology · 2008 · 589 citations · Full text

Medicine, Immunology, Oncology +12

Phase I clinical and pharmacokinetic study of taxol.

Peter H. Wiernik, Edward L. Schwartz, J Strauman et al. · PubMed · 1987 · 454 citations

Pharmacy, Oncology, Pharmacology +14

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

Giuseppe Giaccone, Ted A.W. Splinter, C. Debruyne et al. · Journal of Clinical Oncology · 1998 · 276 citations

Medicine, Oncology, Pharmacology +16

Paclitaxel-Associated Hypersensitivity Reactions: Experience of the Gynecologic Oncology Program of the Cleveland Clinic Cancer Center

Maurie Markman, Alexander Kennedy, Kenneth Webster et al. · Journal of Clinical Oncology · 2000 · 193 citations

Medicine, Oncology, Pharmacotherapy +11